Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment

Oncolytics Biotech announced updates on the GOBLET Phase 1/2 study and that it will receive final payment under the PanCAN grant this quarter.

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.